The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling

Tissue Antigens

Volumn 77, Issue 4, 2011, Pages 271-282

  Inforzato, A ^a   Jaillon, S ^a   Moalli, F ^a   Barbati, E ^a   Bonavita, E ^a   Bottazzi, B ^a   Mantovani, A ^a,b   Garlanda, C ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Angiogenesis; Innate immunity; Pentraxins; Tissue remodelling

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 1BETA; PADGEM PROTEIN; PENTRAXIN 3; SCLEROPROTEIN; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

3' UNTRANSLATED REGION; ACUTE HEART INFARCTION; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ATHEROSCLEROSIS; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CHROMOSOME 3Q; CHRONIC KIDNEY DISEASE; CYTOKINE RELEASE; CYTOMEGALOVIRUS; DENDRITIC CELL; ENDOTHELIUM CELL; EXON; FEMALE FERTILITY; FIBROBLAST; GENE EXPRESSION; GENETIC ORGANIZATION; GENETIC VARIABILITY; HUMAN; INFLAMMATION; INFLUENZA VIRUS A; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE INFECTION; MACROPHAGE; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; OPSONIZATION; PARACOCCIDIOIDES BRASILIENSIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; TISSUE INTERACTION; TISSUE REMODELLING; VASCULAR ENDOTHELIUM;

ANIMALS; C-REACTIVE PROTEIN; EVOLUTION, MOLECULAR; FEMALE; FERTILITY; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; INFECTION; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; SERUM AMYLOID P-COMPONENT;

MUS;

EID: 79952407615     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01645.x     Document Type: Review

References (55)

1. Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010: 28: 157-83.
2. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005: 23: 337-66.
3. Garlanda C, Hirsch E, Bozza S et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002: 420: 182-6.
4. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007: 11: 723-38.
5. Jaillon S, Peri G, Delneste Y et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007: 204: 793-804.
6. Maina V, Cotena A, Doni A et al. Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J Leukoc Biol 2009: 86: 123-32.
7. Sironi M, Conti A, Bernasconi S et al. Generation and characterization of a mouse lymphatic endothelial cell line. Cell Tissue Res 2006: 325: 91-100.
8. Doni A, Michela M, Bottazzi B et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol 2006: 79: 797-802.
9. Salio M, Chimenti S, De Angelis N et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008: 117: 1055-64.
10. Han B, Mura M, Andrade CF et al. TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol 2005: 175: 8303-11.
11. Norata GD, Marchesi P, Pirillo A et al. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 2008: 28: 925-31.
12. Doni A, Mantovani G, Porta C et al. Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. J Biol Chem 2008: 283: 29983-92.
13. Bottazzi B, Vouret-Craviari V, Bastone A et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997: 272: 32817-23.
14. Inforzato A, Peri G, Doni A et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry 2006: 45: 11540-51.
15. Inforzato A, Rivieccio V, Morreale AP et al. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization. J Biol Chem 2008: 283: 10147-61.
16. Inforzato A, Baldock C, Jowitt TA et al. The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J Biol Chem 2010: 285: 17681-92.
17. Reading PC, Bozza S, Gilbertson B et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 2008: 180: 3391-8.
18. Jeannin P, Bottazzi B, Sironi M et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005: 22: 551-60.
19. Nauta AJ, Daha MR, van Kooten C, Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol 2003: 24: 148-54.
20. Deban L, Jarva H, Lehtinen MJ et al. Binding of the long pentraxin PTX3 to Factor H: interacting domains and function in the regulation of complement activation. J Immunol 2008: 181: 8433-40.
21. Ma YJ, Doni A, Hummelshoj T et al. Synergy between ficolin-2 and PTX3 boost innate immune recognition and complement deposition. J Biol Chem 2009: 284: 28263-75.
22. Mantovani A, Locati M, Polentarutti N, Vecchi A, Garlanda C. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and toll-like receptors: the new entry TIR8/SIGIRR. J Leukoc Biol 2004: 75: 738-42.
23. Rusnati M, Camozzi M, Moroni E et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 2004: 104: 92-9.
24. Salustri A, Garlanda C, Hirsch E et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development 2004: 131: 1577-86.
25. Scarchilli L, Camaioni A, Bottazzi B et al. PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem 2007: 282: 30161-70.
26. Moalli F, Doni A, Deban L et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010: 116: 5170-80.
27. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 2008: 456: 989-92.
28. Diniz SN, Nomizo R, Cisalpino PS et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 2004: 75: 649-56.
29. Soares AC, Souza DG, Pinho V et al. Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice. Microbes Infect 2006: 8: 1321-9.
30. Bozza S, Bistoni F, Gaziano R et al. Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 2006: 108: 3387-96.
31. Job ER, Deng YM, Tate MD et al. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 2010: 185: 4284-91.
32. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 2010: 20: 35-40.
33. Deban L, Castro Russo R, Sironi M et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010: 11: 328-34.
34. Dias AA, Goodman AR, Dos Santos JL et al. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol 2001: 69: 928-36.
35. Souza DG, Amaral FA, Fagundes CT et al. The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol 2009: 174: 1309-18.
36. Camozzi M, Zacchigna S, Rusnati M et al. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol 2005: 25: 1837-42.
37. Latini R, Maggioni AP, Peri G et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004: 110: 2349-54.
38. Naito Y, Tsujino T, Akahori H et al. Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis. Am Heart J 2010: 160: 685-91.
39. Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A. Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 2008: 20: 538-44.
40. Nebuloni M, Pasqualini F, Zerbi P et al. PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis. Cardiovasc Pathol 2011: 20: e27-35.
41. Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 2005: 26: 637-43.
42. Russell DL, Salustri A. Extracellular matrix of the cumulus-oocyte complex. Semin Reprod Med 2006: 24: 217-27.
43. Tong M, Carrero JJ, Qureshi AR et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2007: 2: 889-97.
44. Cetin I, Cozzi V, Pasqualini F et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2006: 194: 1347-53.
45. Rovere-Querini P, Antonacci S, Dell'Antonio G et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol 2006: 108: 148-55.
46. Assi F, Fruscio R, Bonardi C et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. BJOG 2007: 114: 143-7.
47. Cruciani L, Romero R, Vaisbuch E et al. Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation. J Perinat Med 2010: 38: 161-71.
48. Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2009: 29: 594-9.
49. Inoue K, Sugiyama A, Reid PC et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2007: 27: 161-7.
50. Kotooka N, Inoue T, Fujimatsu D et al. Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening. Atherosclerosis 2008: 197: 368-74.
51. Olesen R, Wejse C, Velez DR et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 2007: 8: 456-67.
52. Chiarini M, Sabelli C, Melotti P et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun 2010: 11: 665-70.
53. May L, Kuningas M, van Bodegom D et al. Genetic variation in pentraxin (PTX) 3 gene associates with PTX3 production and fertility in women. Biol Reprod 2010: 82: 299-304.
54. Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008: 28: 1-13.
55. Leali D, Alessi P, Coltrini D et al. Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides. Curr Pharm Des 2009: 15: 3577-89.